Renaissance Technologies’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.95M Sell
888,400
-144,565
-14% -$318K ﹤0.01% 2128
2025
Q1
$1.2M Sell
1,032,965
-418,084
-29% -$485K ﹤0.01% 2296
2024
Q4
$1.84M Buy
+1,451,049
New +$1.84M ﹤0.01% 2108
2024
Q3
Sell
-98,429
Closed -$460K 3614
2024
Q2
$460K Sell
98,429
-799,989
-89% -$3.74M ﹤0.01% 2731
2024
Q1
$6.67M Buy
898,418
+391,018
+77% +$2.9M 0.01% 1232
2023
Q4
$5.14M Buy
507,400
+442,900
+687% +$4.49M 0.01% 1327
2023
Q3
$503K Sell
64,500
-91,800
-59% -$716K ﹤0.01% 2701
2023
Q2
$1.29M Buy
+156,300
New +$1.29M ﹤0.01% 2309
2022
Q2
Sell
-903,400
Closed -$17.2M 4302
2022
Q1
$17.2M Buy
903,400
+675,300
+296% +$12.8M 0.02% 839
2021
Q4
$6.06M Buy
+228,100
New +$6.06M 0.01% 1398
2021
Q3
Sell
-140,000
Closed -$7.93M 3551
2021
Q2
$7.93M Sell
140,000
-315,927
-69% -$17.9M 0.01% 1335
2021
Q1
$19.1M Buy
+455,927
New +$19.1M 0.02% 797
2020
Q4
Sell
-106,100
Closed -$2.98M 3451
2020
Q3
$2.98M Sell
106,100
-94,000
-47% -$2.64M ﹤0.01% 1880
2020
Q2
$5.92M Sell
200,100
-100,800
-33% -$2.98M 0.01% 1533
2020
Q1
$5.97M Buy
300,900
+218,800
+267% +$4.34M 0.01% 1464
2019
Q4
$2.43M Buy
+82,100
New +$2.43M ﹤0.01% 2227
2019
Q2
Sell
-371,400
Closed -$9.08M 3589
2019
Q1
$9.08M Buy
371,400
+99,400
+37% +$2.43M 0.01% 1435
2018
Q4
$6.19M Sell
272,000
-28,100
-9% -$639K 0.01% 1586
2018
Q3
$9.55M Buy
+300,100
New +$9.55M 0.01% 1390
2016
Q4
Sell
-128,400
Closed -$1.73M 3291
2016
Q3
$1.73M Buy
128,400
+106,096
+476% +$1.43M ﹤0.01% 2278
2016
Q2
$544K Buy
+22,304
New +$544K ﹤0.01% 2766